Professional Documents
Culture Documents
Title of Assessment:
Case Study
Word Count: Campus/Site:
2000 per case Mental Health
Date Assessment due: Date Assessment Submitted:
21st March 2022 19th
March 2022
Declaration of Academic integrity:
1. I confirm that this is all my own work and that any information copied in part or full including
references and quotations from both primary and secondary sources have been fully identified and
properly acknowledged in line with the Guidelines on Referencing and Citation Style in Health
and Social Science (www.lr.mdx.ac.uk/helpsheets/study_skills/hss.pdf)
2. I have read the regulations relating to academic misconduct and submit this work as my own in
line with those regulations. (www.mdx.ac.uk/24-7/assess/index.htm)
3. I understand that my work may be compared against the work of others for the purposes of
detecting plagiarism and collusion. When software is used for this purpose, I am aware this will
mean it will be held on a (secure) external database for the sole purpose of detecting plagiarism.
When requested by the module tutor, I agree to provide an electronic copy of the work.
4. This work has not been submitted previously towards any credit bearing component of an award.
Please sign and enter your student number here to confirm adherence to the above:
The diagnosis for Myra is dementia due to Alzheimer’s disease [6D80] the description
is “The characteristic course is a slow but steady decline from a previous level of cognitive
functioning with impairment in additional cognitive domains (such as executive functions,
attention, language, social cognition and judgment, psychomotor speed, visuoperceptual or
visuospatial abilities) emerging with disease progression. Dementia due to Alzheimer’s
disease may be accompanied by mental and behavioural symptoms such as depressed mood
and apathy in the initial stages of the disease and may be accompanied by psychotic
symptoms, irritability, aggression, confusion, abnormalities of gait and mobility, and seizures
at later stages. Positive genetic testing, family history and gradual cognitive decline are
suggestive of Dementia due to Alzheimer's disease”. To avoid misinterpretation at the
diagnostic requirements following ICD-11(2022) is “dementia is presumed to be attributable
to underlying Alzheimer Disease (8A20) based on quantified clinical assessment or
standardized neuropsychological/cognitive testing, neuroimaging data, genetic testing,
medical tests, family history, and/or clinical history” and “early clinical history is typically
characterized by gradual onset, progressive memory problems and word-finding difficulties,
as well as mild functional impairment. The most common form of Alzheimer Disease begins
with neuronal impairment in the medial temporal lobes (the brain regions involved in
memory formation). As Alzheimer Disease progresses and affects other brain regions,
neurocognitive symptoms worsen. Atypical forms of Alzheimer Disease are also
characterized by progressive neurocognitive and functional impairment, with initial
neurocognitive symptoms often corresponding to the brain region(s) initially affected (e.g.,
visual processing impairment in posterior cortical atrophy, etc.)” (International Classification
of Diseases-11, 2022).
Initially, Myra meets the criteria to be diagnosed with Alzheimer’s dementia. However, a
professional report about her mobility decrease showed by fallings. A study finds that the
quantitative balance and gait measurement in patients with frontotemporal dementia (FTD)
and Alzheimer diseases (AD) have a differential pattern of balance and gait impairment
(Velayutham, S., et all., 2017) between them. To prevent falls, the services users with AD
must be training in postural stability and services users with FTD could do gait training.
Overall, it may be said Myra is suffering from a chronic mental illness. The concern
on the table is her well-being, the level of depression or isolation is suffering her family.
Finds ways with the therapies to work harder in being involved with her family in her
therapy. As a professional to be updated for new generation medicaments and new generation
therapies for Alzheimer’s dementia. To protect and prevent healthcare for the burnout
syndrome which can be affected to the services and care to the person who is living and be
treated in residential care. Another important concern is to help the family with the process of
bereavement for the advanced age of Myra and her anosognosia will progress when the
illness advances itself. It stands shoulder-to-shoulder between family and professionals for
the best recovery for Myra.
Cohen, L.W., Zimmerman, S., Reed, D., Sloane, P.D., Beeber, A.S., Washington, T., Cagle,
J.G. and Gwyther, L.P., 2014. Dementia in relation to family caregiver involvement and
burden in long-term care. Journal of Applied Gerontology, 33(5), pp.522-540.
Hamilton, J.R., 1983. Mental Health Act 1983. British Medical Journal (Clinical Research
Ed.), 286(6379), p.1720.
Lichtwarck, B., Myhre, J., Selbaek, G., Kirkevold, Ø., Rokstad, A.M.M., Benth, J.Š. and
Bergh, S., 2019. TIME to reduce agitation in persons with dementia in nursing homes. A
process evaluation of a complex intervention. BMC health services research, 19(1), pp.1-16.
Mind. 2020. Sectioning. [ONLINE] Available at: https://www.mind.org.uk/information-
support/legal-rights/sectioning/overview/. [Accessed 19 March 2022].
Mok, V.C., Pendlebury, S., Wong, A., Alladi, S., Au, L., Bath, P.M., Biessels, G.J., Chen, C.,
Cordonnier, C., Dichgans, M. and Dominguez, J., 2020. Tackling challenges in care of
Alzheimer's disease and other dementias amid the COVID‐19 pandemic, now and in the
future. Alzheimer's & Dementia, 16(11), pp.1571-1581.
Peluso, S., De Rosa, A., De Lucia, N., Antenora, A., Illario, M., Esposito, M. and De
Michele, G., 2018. Animal-assisted therapy in elderly patients: Evidence and controversies in
dementia and psychiatric disorders and future perspectives in other neurological
diseases. Journal of geriatric psychiatry and neurology, 31(3), pp.149-157.
Pink, J., O’Brien, J., Robinson, L. and Longson, D., 2018. Dementia: assessment,
management and support: summary of updated NICE guidance. bmj, 361.
Quality compliance systems. 2021. LPS and DoLS – How are they different?. [ONLINE]
Available at: https://www.qcs.co.uk/lps-and-dols-how-are-they-different/. [Accessed 19
March 2022].
Rosin, E.R., Blasco, D., Pilozzi, A.R., Yang, L.H. and Huang, X., 2020. A narrative review
of Alzheimer’s disease stigma. Journal of Alzheimer's Disease, 78(2), pp.515-528.
Scuteri, D., Morrone, L.A., Rombolà, L., Avato, P.R., Bilia, A.R., Corasaniti, M.T.,
Sakurada, S., Sakurada, T. and Bagetta, G., 2017. Aromatherapy and aromatic plants for the
treatment of behavioural and psychological symptoms of dementia in patients with
alzheimer’s disease: clinical evidence and possible mechanisms. Evidence-Based
Complementary and Alternative Medicine, 2017.
Strøm, B.S., Ytrehus, S. and Grov, E.K., 2016. Sensory stimulation for persons with
dementia: a review of the literature. Journal of clinical nursing, 25(13-14), pp.1805-1834.
Swaffer, K., 2014. Dementia: stigma, language, and dementia friendly. Dementia, 13(6),
pp.709-716.
Taylor, M.K., Sullivan, D.K., Mahnken, J.D., Burns, J.M. and Swerdlow, R.H., 2018.
Feasibility and efficacy data from a ketogenic diet intervention in Alzheimer's
disease. Alzheimer's & Dementia: Translational Research & Clinical Interventions, 4, pp.28-
36.
Velayutham, S.G., Chandra, S.R., Bharath, S. and Shankar, R.G., 2017. Quantitative balance
and gait measurement in patients with frontotemporal dementia and Alzheimer diseases: a
pilot study. Indian journal of psychological medicine, 39(2), pp.176-182.
Voisin, T. and Vellas, B., 2009. Diagnosis and treatment of patients with severe Alzheimer’s
disease. Drugs & aging, 26(2), pp.135-144.
Areas for improvement identified from previous feedback on assignments from previous studies, including
formative assessment from this module, that I have endeavoured to address.
My knowledge and vocabulary are increased drastically. At the same time, the review of the last research in the last
ten years, make me change my perspective of the new world after COVID-19.
Things which were difficult and I’m not too happy about and I would particularly like comments on:
My vocabulary can be better and use more formal words and more academic expressions.
Other comments: